|
|||||
|
|
Enrichment of kinase fusions in ESR1 wild-type,metastatic breast cancer revealed by a systematic analysis of 4854 patients |
|
| Institution: | 1. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA;2. Human Oncology and Pathogenesis Program;3. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA;4. Department of Pathology, Columbia University Medical Center, New York, USA |
| Abstract: | |
| Keywords: | breast cancer endocrine therapy kinase fusion larotrectinib resistance |
| 本文献已被 ScienceDirect 等数据库收录！ | |